Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients

Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceft...

Descripción completa

Detalles Bibliográficos
Autores principales: Onogi, Chikao, Osada, Akinori, Imai, Kentaro, Mimura, Tetsushi, Saka, Yosuke, Urahama, Yoshimichi, Oishi, Hideto, Naruse, Tomohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545014/
https://www.ncbi.nlm.nih.gov/pubmed/35441472
http://dx.doi.org/10.1111/hdi.13018
_version_ 1784804726012903424
author Onogi, Chikao
Osada, Akinori
Imai, Kentaro
Mimura, Tetsushi
Saka, Yosuke
Urahama, Yoshimichi
Oishi, Hideto
Naruse, Tomohiko
author_facet Onogi, Chikao
Osada, Akinori
Imai, Kentaro
Mimura, Tetsushi
Saka, Yosuke
Urahama, Yoshimichi
Oishi, Hideto
Naruse, Tomohiko
author_sort Onogi, Chikao
collection PubMed
description Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceftriaxone. We experienced two cases of ceftriaxone‐induced encephalopathy that were successfully treated by rapid removal of ceftriaxone by hemoperfusion.
format Online
Article
Text
id pubmed-9545014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95450142022-10-14 Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients Onogi, Chikao Osada, Akinori Imai, Kentaro Mimura, Tetsushi Saka, Yosuke Urahama, Yoshimichi Oishi, Hideto Naruse, Tomohiko Hemodial Int Case Reports Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceftriaxone. We experienced two cases of ceftriaxone‐induced encephalopathy that were successfully treated by rapid removal of ceftriaxone by hemoperfusion. John Wiley & Sons, Inc. 2022-04-19 2022-07 /pmc/articles/PMC9545014/ /pubmed/35441472 http://dx.doi.org/10.1111/hdi.13018 Text en © 2022 The Authors. Hemodialysis International published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Onogi, Chikao
Osada, Akinori
Imai, Kentaro
Mimura, Tetsushi
Saka, Yosuke
Urahama, Yoshimichi
Oishi, Hideto
Naruse, Tomohiko
Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
title Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
title_full Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
title_fullStr Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
title_full_unstemmed Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
title_short Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
title_sort two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545014/
https://www.ncbi.nlm.nih.gov/pubmed/35441472
http://dx.doi.org/10.1111/hdi.13018
work_keys_str_mv AT onogichikao twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT osadaakinori twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT imaikentaro twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT mimuratetsushi twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT sakayosuke twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT urahamayoshimichi twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT oishihideto twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients
AT narusetomohiko twocasesofceftriaxoneinducedencephalopathytreatedbyhemoperfusioninhemodialysispatients

Ejemplares similares